GlySens
is a California-based medical device company that designs and develops glucose monitoring systems for diabetes patients... Read moreGlySens
is a California-based medical device company that designs and develops glucose monitoring systems for diabetes patients... Read more
News
Jun 12, 2020
Medical Device News Magazine
GlySens: GlySens Incorporated Closes Incremental $15 Million Financing
Oct 26, 2018
BioPortfolio
GlySens: GlySens Inc Medical Equipment Deals and Alliances Profile Report Updated 15102018 Prices from USD $250
Aug 02, 2018
BioPortfolio
GlySens: GlySens Inc Medical Equipment Deals and Alliances Profile Report Updated 11052018 Prices from USD $250
Aug 23, 2017
BioPortfolio
GlySens: GlySens Inc Medical Equipment Deals and Alliances Profile Report Updated 12072017 Prices from USD $250
Feb 26, 2017
BioPortfolio
GlySens: GlySens Inc Medical Equipment Deals and Alliances Profile Updated 24012017 Prices from USD $250
Nov 16, 2016
BioPortfolio
GlySens: GlySens Incorporated Medical Equipment Deals and Alliances Profile Prices from USD $250
Apr 06, 2016
San Diego Business Journal
GlySens: GlySens Inc. Moves to New Corporate Headquarters
Mar 30, 2016
Business Wire
Press Release: GlySens : Europe Continuous Glucose Monitoring Systems Market Worth USD 351.7 Million by 2021 - Analysis Technologies & Forecasts Report 2014-2021 - Key Vendors: Abbott Diabetic Care, Dexcom, Medtronic - Research and Markets
Jan 05, 2016
BioSpace
GlySens: GlySens Secures $20 Million Series D Investment To Advance Its Fully Implanted, Long-Term Continuous Glucose Monitoring System
Jan 05, 2016
FinSMEs
GlySens: GlySens Closes $20M Series D Financing
GlySens Competitors
1
2
3
4
5
6
7
8
9